GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Expensive Performer

1398.2000 -20.70 (-1.46%)

NSE May 09, 2025 15:31 PM

41.92% Gain from 52W Low

Volume: 480.0K

Glenmark Pharmaceuticals Ltd.

21 Sep 2023

1398.20

-1.46%

Company Update

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Glenmark Pharma announces proposed Divestment of Majority Stake in Glenmark Life Sciences Limited

More from Glenmark Pharmaceuticals Ltd.

Recommended

Five Interesting Stocks Today - May 09, 2025

The Baseline | 09 May 2025, 04:56PM

Market closes lower, Intellect Design Arena's Q4 net profit surges 93% QoQ to Rs 135.3 crore

Trendlyne Marketwatch | 09 May 2025, 03:56PM

Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals